FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Can J Vet Res / Characterization of endothelin receptors in the peripheral l...
Canadian journal of veterinary research = Revue canadienne de recherche veterinaire2008; 72(4); 340-349;

Characterization of endothelin receptors in the peripheral lung tissues of horses unaffected and affected with recurrent airway obstruction.

Abstract: The purpose of the study was to determine and compare the expression of endothelin (ET) receptors in the peripheral lungs of healthy horses and those affected with recurrent airway obstruction (RAO) using reverse transcriptase polymerase chain reaction (RT-PCR), real-time PCR, Western blot analysis, and immunohistochemical techniques. Two groups of horses (7 healthy and 7 RAO-affected) were selected from a pool of horses destined for euthanasia. The grouping of horses was based on the history, clinical scoring, and pulmonary function testing. After euthanasia, gross postmortem evaluation of the lungs was conducted, and lung samples were collected and either stored at -80 degrees C or fixed in zinc-formalin for 12 h. The RT-PCR was performed by using specific primers for ETA and ETB receptors, and beta-actin. To determine the relative gene expression real-time PCR was performed. To detect ET receptor protein expression, Western blotting and immunohistochemical studies were performed using polyclonal antibodies against ETA and ETB receptors and beta-actin. The ET receptor expression was determined by performing either densitometric analyses or scoring of immunostaining. Statistical analyses were performed to detect differences in receptor expression within and between the 2 groups. The results indicated that ET receptor expression, particularly ETB receptors, was significantly greater in the peripheral lungs of RAO-affected horses than in those of healthy horses. Clinical trials using ET receptor antagonists, particularly ETB antagonists might help in developing a therapeutic strategy to treat this career-ending disease. L’objectif de la présente étude était de déterminer et comparer l’expression des récepteurs de l’endothéline (ET) dans les poumons périphériques de chevaux en santé et de chevaux souffrant d’obstruction récurrente des voies respiratoires (RAO) par réaction d’amplification en chaîne par la polymérase à l’aide de la transcriptase réverse (RT-PCR), par PCR en temps réel, par réaction d’immunobuvardage et par techniques immunohistochimiques. Deux groupes de chevaux (7 en santé et 7 atteints de RAO) ont été sélectionnés à partir d’un regroupement de chevaux destinés à l’euthanasie. Le groupement des chevaux s’est fait sur la base de l’anamnèse, le pointage clinique, et un test de fonction respiratoire. Après l’euthanasie, une évaluation des lésions macroscopiques des poumons a été faite, et des échantillons de poumons prélevés et soit entreposés à −80 °C ou fixé pendant 12 h dans une solution de zinc-formaline. L’épreuve de RT-PCR a été effectuée en utilisant des amorces spécifiques pour les récepteurs ETA et ETB, et β-actine. Afin de déterminer l’expression génique relative une épreuve de PCR en temps réel a été effectuée. Afin de déterminer l’expression des récepteurs ET, les épreuves d’immunobuvardage et immunohistochimiques ont été effectuées en utilisant des anticorps polyclonaux contre les récepteurs d’ETA et d’ETB ainsi que ceux pour β-actine. L’expression de récepteur ET a été déterminée en réalisant des analyses densitométriques ou en attribuant un pointage à l’immunocoloration. Les analyses statistiques ont été faites afin de détecter des différences dans l’expression des récepteurs à l’intérieur et entre les 2 groupes. Les résultats indiquent que l’expression des récepteurs ET, en particulier les récepteurs ETB, était significativement plus grande dans les poumons périphériques des chevaux atteints de RAO que ceux des chevaux en santé. Des essais cliniques utilisant des antagonistes des récepteurs ET, plus particulièrement les antagonistes ETB, pourraient aider au développement d’une stratégie pour traiter cette maladie qui met fin à une carrière. (Traduit par Docteur Serge Messier)
Get Full Text
Publication Date: 2008-09-12 PubMed ID: 18783023PubMed Central: PMC2442677
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Research Support
  • U.S. Gov't
  • Non-P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study aimed to evaluate and contrast the presence of endothelin receptors in the lungs of both healthy horses and horses suffering from recurrent airway obstruction (RAO). The test results indicated that horses with RAO have a significantly higher expression of these receptors, particularly ETB receptors, compared to healthy horses, suggesting ET receptor antagonists could be beneficial in treating this ailment.

Objective and Methodology

  • The study was designed to understand the expression of Endothelin (ET) receptors in the peripheral lungs of healthy horses and those with recurrent airway obstruction (RAO).
  • Fourteen horses were selected for the study, seven of which were healthy and seven of which were suffering from RAO. Selection was based on their medical history, clinical scoring, and pulmonary function.
  • The horses were eventually euthanized, and postmortem examination of the lungs was conducted to collect lung samples.
  • The lung samples were stored at extreme low temperatures or fixed in zinc-formalin for 12 hours.

Experimental Procedures

  • Reverse transcriptase polymerase chain reaction (RT-PCR), real-time PCR, Western blot analysis, and immunohistochemical techniques were used in the study. These are standard methods to detect and quantify specific genes and proteins in tissue samples.
  • For RT-PCR, specific primers for ETA and ETB receptors, and beta-actin were used.
  • Real-time PCR was performed to determine the relative gene expression. Western blotting and immunohistochemical studies were performed to detect ET receptor protein expression.
  • The studies used polyclonal antibodies against ETA and ETB receptors and beta-actin.
  • The density of the receptor expression was determined either by densitometric analyses or by scoring the immunostaining.
  • Statistical analysis was used to detect and quantify differences in receptor expression both within the same group of horses and between the two groups.

Findings and Implications

  • Results showed that the expression of ET receptors, especially ETB receptors, was significantly higher in RAO-affected horses than in healthy horses.
  • This discovery implies that these receptors might play a significant role in the development or persistence of RAO in horses.
  • The findings suggest that treating RAO-affected horses with ET receptor antagonists, particularly ETB antagonists, might help in controlling this debilitating disease.

Cite This Article

APA
Polikepahad S, Haque M, Francis J, Moore RM, Venugopal CS. (2008). Characterization of endothelin receptors in the peripheral lung tissues of horses unaffected and affected with recurrent airway obstruction. Can J Vet Res, 72(4), 340-349.

Publication

Canadian journal of veterinary research = Revue canadienne de recherche veterinaire
ISSN: 0830-9000
NlmUniqueID: 8607793
Country: Canada
Language: English
Volume: 72
Issue: 4
Pages: 340-349

Researcher Affiliations

Polikepahad, Sumanth
  • Equine Health Studies Program, Department of Comparative Biomedical Sciences, Louisiana State University, Baton Rouge, Louisiana, 70803 USA.
Haque, Masudul
    Francis, Joseph
      Moore, Rustin M
        Venugopal, Changaram S

          MeSH Terms

          • Animals
          • Blotting, Western / veterinary
          • Case-Control Studies
          • Densitometry
          • Gene Expression
          • Horse Diseases / metabolism
          • Horses
          • Immunohistochemistry / veterinary
          • Lung / metabolism
          • Lung / pathology
          • Lung Diseases, Obstructive / metabolism
          • Lung Diseases, Obstructive / veterinary
          • Polymerase Chain Reaction / veterinary
          • Receptors, Endothelin / genetics
          • Receptors, Endothelin / metabolism
          • Reverse Transcriptase Polymerase Chain Reaction / veterinary

          References

          This article includes 35 references
          1. Robinson NE, Derksen FJ, Olszewski MA, Buechner-Maxwell VA. The pathogenesis of chronic obstructive pulmonary disease of horses.. Br Vet J 1996 May;152(3):283-306.
            pubmed: 8762605doi: 10.1016/s0007-1935(96)80101-1google scholar: lookup
          2. Seahorn TL, Beadle RE. Summer pasture-associated obstructive pulmonary disease. Equine pract 1994;16:39–41.
          3. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology.. Pharmacol Rev 1994 Sep;46(3):325-415.
            pubmed: 7831383
          4. de Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor.. Proc Natl Acad Sci U S A 1988 Dec;85(24):9797-800.
            pmc: PMC282868pubmed: 3059352doi: 10.1073/pnas.85.24.9797google scholar: lookup
          5. Tsukahara H, Ende H, Magazine HI, Bahou WF, Goligorsky MS. Molecular and functional characterization of the non-isopeptide-selective ETB receptor in endothelial cells. Receptor coupling to nitric oxide synthase.. J Biol Chem 1994 Aug 26;269(34):21778-85.
            pubmed: 7520443
          6. Martin C, Held HD, Uhlig S. Differential effects of the mixed ET(A)/ET(B)-receptor antagonist bosentan on endothelin-induced bronchoconstriction, vasoconstriction and prostacyclin release.. Naunyn Schmiedebergs Arch Pharmacol 2000 Aug;362(2):128-36.
            pubmed: 10961375doi: 10.1007/s002100000264google scholar: lookup
          7. Emanueli C, Ricciardolo F, Vergnani L, Bertrand C, Ricci F, Manzoli N, Folkerts G, Nijkamp FP, Geppetti P. Characterization of the endothelin receptor subtype mediating epithelium-derived relaxant nitric oxide release from guinea-pig trachea.. Br J Pharmacol 1998 Nov;125(5):963-8.
            pmc: PMC1565678pubmed: 9846633doi: 10.1038/sj.bjp.0702174google scholar: lookup
          8. Henry PJ, Goldie RG. Potentiation by endothelin-1 of cholinergic nerve-mediated contractions in mouse trachea via activation of ETB receptors.. Br J Pharmacol 1995 Feb;114(3):563-9.
            pmc: PMC1510007pubmed: 7735683doi: 10.1111/j.1476-5381.1995.tb17176.xgoogle scholar: lookup
          9. Fernandes LB, Henry PJ, Rigby PJ, Goldie RG. EndothelinB (ETB) receptor-activated potentiation of cholinergic nerve-mediated contraction in human bronchus.. Br J Pharmacol 1996 Aug;118(8):1873-4.
            pmc: PMC1909875pubmed: 8864516doi: 10.1111/j.1476-5381.1996.tb15617.xgoogle scholar: lookup
          10. Yoneyama T, Hori M, Tanaka T, Matsuda Y, Karaki H. Endothelin ETA and ETB receptors facilitating parasympathetic neurotransmission in the rabbit trachea.. J Pharmacol Exp Ther 1995 Dec;275(3):1084-9.
            pubmed: 8531067
          11. Knott PG, Fernandes LB, Henry PJ, Goldie RG. Influence of endothelin-1 on cholinergic nerve-mediated contractions and acetylcholine release in rat isolated tracheal smooth muscle.. J Pharmacol Exp Ther 1996 Dec;279(3):1142-7.
            pubmed: 8968335
          12. Bagnato A, Natali PG. Endothelin receptors as novel targets in tumor therapy.. J Transl Med 2004 May 27;2(1):16.
            pmc: PMC436068pubmed: 15165288doi: 10.1186/1479-5876-2-16google scholar: lookup
          13. Finsnes F, Lyberg T, Christensen G, Skjønsberg OH. Effect of endothelin antagonism on the production of cytokines in eosinophilic airway inflammation.. Am J Physiol Lung Cell Mol Physiol 2001 Apr;280(4):L659-65.
            pubmed: 11238005doi: 10.1152/ajplung.2001.280.4.l659google scholar: lookup
          14. Roland M, Bhowmik A, Sapsford RJ, Seemungal TA, Jeffries DJ, Warner TD, Wedzicha JA. Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease.. Thorax 2001 Jan;56(1):30-5.
            pmc: PMC1745915pubmed: 11120901doi: 10.1136/thorax.56.1.30google scholar: lookup
          15. Hay DW, Goldie RG. Potential pathophysiological role of endothelin-1 in asthma.. Drug News Perspect 1998 Sep;11(7):411-8.
            pubmed: 15616682doi: 10.1358/dnp.1998.11.7.660500google scholar: lookup
          16. Benamou AE, Art T, Marlin DJ, Roberts CA, Lekeux P. Variations in systemic and pulmonary endothelin-1 in horses with recurrent airway obstruction (heaves).. Pulm Pharmacol Ther 1998 Apr-Jun;11(2-3):231-5.
            pubmed: 9918762doi: 10.1006/pupt.1998.0144google scholar: lookup
          17. Benamou AE, Marlin DJ, Callingham BC, Hiley RC, Lekeux R. Spasmogenic action of endothelin-1 on isolated equine pulmonary artery and bronchus.. Equine Vet J 2003 Mar;35(2):190-6.
            pubmed: 12638797doi: 10.2746/042516403776114243google scholar: lookup
          18. Venugopal CS, Polikepahad S, Holmes EP, Heuvel JV, Leas TL, Moore RM. Endothelin receptor alterations in equine airway hyperreactivity.. Can J Vet Res 2006 Jan;70(1):50-7.
            pmc: PMC1325094pubmed: 16548332
          19. Polikepahad S, Paulsen DB, Moore RM, Costa LR, Venugopal CS. Immunohistochemical determination of the expression of endothelin receptors in bronchial smooth muscle and epithelium of healthy horses and horses affected by summer pasture-associated obstructive pulmonary disease.. Am J Vet Res 2006 Feb;67(2):348-57.
            pubmed: 16454644doi: 10.2460/ajvr.67.2.348google scholar: lookup
          20. Seahorn TL, Beadle RE. Summer pasture-associated obstructive pulmonary disease in horses: 21 cases (1983-1991).. J Am Vet Med Assoc 1993 Mar 1;202(5):779-82.
            pubmed: 8454516
          21. Seahorn TL, Beadle RE, McGorum BC, Marley CL. Quantification of antigen-specific antibody concentrations in tracheal lavage fluid of horses with summer pasture-associated obstructive pulmonary disease.. Am J Vet Res 1997 Dec;58(12):1408-11.
            pubmed: 9401689
          22. Yang GC, Croaker D, Zhang AL, Manglick P, Cartmill T, Cass D. A dinucleotide mutation in the endothelin-B receptor gene is associated with lethal white foal syndrome (LWFS); a horse variant of Hirschsprung disease.. Hum Mol Genet 1998 Jun;7(6):1047-52.
            pubmed: 9580670doi: 10.1093/hmg/7.6.1047google scholar: lookup
          23. Wendel-Wellner M, Noll T, König P, Schmeck J, Koch T, Kummer W. Cellular localization of the endothelin receptor subtypes ET(A) and ET(B) in the rat heart and their differential expression in coronary arteries, veins, and capillaries.. Histochem Cell Biol 2002 Nov;118(5):361-9.
            pubmed: 12432447doi: 10.1007/s00418-002-0457-4google scholar: lookup
          24. McMullan DM, Bekker JM, Johengen MJ, Hendricks-Munoz K, Gerrets R, Black SM, Fineman JR. Inhaled nitric oxide-induced rebound pulmonary hypertension: role for endothelin-1.. Am J Physiol Heart Circ Physiol 2001 Feb;280(2):H777-85.
            pubmed: 11158977doi: 10.1152/ajpheart.2001.280.2.h777google scholar: lookup
          25. Black SM, Johengen MJ, Ma ZD, Bristow J, Soifer SJ. Ventilation and oxygenation induce endothelial nitric oxide synthase gene expression in the lungs of fetal lambs.. J Clin Invest 1997 Sep 15;100(6):1448-58.
            pmc: PMC508323pubmed: 9294110doi: 10.1172/jci119665google scholar: lookup
          26. Furuya S, Furuya K, Sokabe M, Hiroe T, Ozaki T. Characteristics of cultured subepithelial fibroblasts in the rat small intestine. II. Localization and functional analysis of endothelin receptors and cell-shape-independent gap junction permeability.. Cell Tissue Res 2005 Jan;319(1):103-19.
            pubmed: 15503148doi: 10.1007/s00441-004-0958-7google scholar: lookup
          27. De Falco M, Laforgia V, Fedele V, Russo T, De Luca L, Cottone G, Varano L, De Luca A. Endothelin-B (ET(B)) receptor distribution in tissues of the lizard Podarcis sicula.. Cell Tissue Res 2002 Sep;309(3):381-6.
            pubmed: 12195294doi: 10.1007/s00441-002-0603-2google scholar: lookup
          28. Naylor JM, Clark EG, Clayton HM. Chronic obstructive pulmonary disease: Usefulness of clinical signs, bronchoalveolar lavage, and lung biopsy as diagnostic and prognostic aids.. Can Vet J 1992 Sep;33(9):591-8.
            pmc: PMC1481327pubmed: 17424075
          29. Costa LR, Seahorn TL, Moore RM, Taylor HW, Gaunt SD, Beadle RE. Correlation of clinical score, intrapleural pressure, cytologic findings of bronchoalveolar fluid, and histopathologic lesions of pulmonary tissue in horses with summer pasture-associated obstructive pulmonary disease.. Am J Vet Res 2000 Feb;61(2):167-73.
            pubmed: 10685689doi: 10.2460/ajvr.2000.61.167google scholar: lookup
          30. Möller S, Uddman R, Granström B, Edvinsson L. Altered ratio of endothelin ET(A)- and ET(B) receptor mRNA in bronchial biopsies from patients with asthma and chronic airway obstruction.. Eur J Pharmacol 1999 Jan 15;365(1):R1-3.
            pubmed: 9988131doi: 10.1016/s0014-2999(98)00864-4google scholar: lookup
          31. Knott PG, D'Aprile AC, Henry PJ, Hay DW, Goldie RG. Receptors for endothelin-1 in asthmatic human peripheral lung.. Br J Pharmacol 1995 Jan;114(1):1-3.
            pmc: PMC1510163pubmed: 7712003doi: 10.1111/j.1476-5381.1995.tb14895.xgoogle scholar: lookup
          32. Fukuroda T, Fujikawa T, Ozaki S, Ishikawa K, Yano M, Nishikibe M. Clearance of circulating endothelin-1 by ETB receptors in rats.. Biochem Biophys Res Commun 1994 Mar 30;199(3):1461-5.
            pubmed: 8147891doi: 10.1006/bbrc.1994.1395google scholar: lookup
          33. Santschi EM, Purdy AK, Valberg SJ, Vrotsos PD, Kaese H, Mickelson JR. Endothelin receptor B polymorphism associated with lethal white foal syndrome in horses.. Mamm Genome 1998 Apr;9(4):306-9.
            pubmed: 9530628doi: 10.1007/s003359900754google scholar: lookup
          34. Adner M, Cardell LO, Sjöberg T, Ottosson A, Edvinsson L. Contractile endothelin-B (ETB) receptors in human small bronchi.. Eur Respir J 1996 Feb;9(2):351-5.
            pubmed: 8777976doi: 10.1183/09031936.96.09020351google scholar: lookup
          35. Granström BW, Xu CB, Nilsson E, Bengtsson UH, Edvinsson L. Up-regulation of endothelin receptor function and mRNA expression in airway smooth muscle cells following Sephadex-induced airway inflammation.. Basic Clin Pharmacol Toxicol 2004 Jul;95(1):43-8.
            pubmed: 15245576doi: 10.1111/j.1742-7843.2004.pto950109.xgoogle scholar: lookup

          Citations

          This article has been cited 0 times.
          Subscribe to our newsletter
          Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.